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This document has been developed as a health policy
statement by the American College of Cardiology (ACC).
Health policy statements are intended to promote or
advocate a position, be informational in nature, and offer
guidance to the stakeholder community regarding the
stance of the ACC and other contributing organizations on
healthcare policies and programs. Health policy state-
ments are not intended to offer clinical guidance and do
not contradict existing ACC clinical policy. They are
typically overseen by the ACC Clinical Quality Committee,
the group that represents an intersection of the work of
the Science, Education, and Quality division and that of
the Advocacy division of the College. The topic of team-
based care was identiﬁed by the Clinical Quality Com-
mittee as an area of interest for a health policy statement
in 2013, and an outline was circulated to various stake-
holders who might be relevant to its development. During
this process, the Board of Trustees and Executive Com-
mittee noted the speciﬁc need to clarify the College’s
position on the role of advanced practice providers
in team-based care. Given the core constituency that
advanced practice providers represent within the ACC
and the complexity of the issues that might be addressed,
the Board of Trustees and Executive Committee elected to
take oversight responsibility for this statement. The
Board and Executive Committee also engaged the Car-
diovascular Team Section of the College, which had also
been organizing a stakeholder roundtable summit to
discuss team-based care. In the course of preparation of
the document and summit, the scope of this statement
was narrowed from the original Clinical Quality Com-
mittee proposal, which covered a broad range of topics
on team-based care, to focus on the skills and exper-
tise of speciﬁc team members, their education, andpotential organizational models. The summit was held in
November, 2014, during which these topics were dis-
cussed in depth. The statement was drafted subse-
quently to summarize the information presented at the
summit, and the resulting position is reﬂected in this
statement.
To avoid actual, potential, or perceived conﬂicts of
interest that may arise as a result of industry relationships
or personal interests among the writing committee, all
members of the writing committee, as well as peer re-
viewers of the document, are asked to disclose all current
healthcare-related relationships, including those existing
12 months before initiation of the writing effort. These
disclosures are reviewed to determine what companies
make products (on market or in development) that
pertain to the document under development. Based on
this information, a writing committee is formed to include
a majority of members with no relevant relationships
with industry (RWI) and other entities, led by a chair with
no relevant RWI. Authors with relevant RWI are not
permitted to vote on recommendations pertaining to
their RWI. On all conference calls, RWI is reviewed and
updated as changes occur. Author and peer reviewer RWI
pertinent to this document are disclosed in Appendixes 1
and 2, respectively. In addition, to ensure complete trans-
parency, authors’ comprehensive disclosure information—
including RWI not pertinent to this document—is
available as an online supplement to this document.
The ACC disclosure policy for document develop-
ment is also available online. The work of the writing
committee was supported exclusively by the ACC without
commercial support. Writing committee members vol-
unteered their time to this effort. Conference calls of the
writing committee were conﬁdential and were attended
only by committee members.
Patrick O’Gara, MD, MACC
Immediate ACC Past President
1. INTRODUCTION
1.1. Document Development Process
1.1.1. Writing Committee Organization
The ACC has a long-standing commitment to the concept
of cardiovascular team-based care. For decades, our
members have worked collaboratively within multidis-
ciplinary teams that include cardiovascular nurses,
technologists, cardiac surgeons, primary care physicians,
and other specialists. More recently, we have seen
the emergence of a group of team members that we
will refer to collectively as advanced practice pro-
viders (APPs). This group includes advanced practice
registered nurses (APRNs), physician assistants (PAs),
and pharmacists (PharmDs). This position paper is meant
speciﬁcally to address the policy of the ACC on
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tributions of APPs.
1.1.1.1. Background and Rationale
The College reached out to nonphysician members of the
cardiac care team in 2003, when the ACC Board of
Trustees approved a new cardiac care associate member-
ship category for cardiovascular registered nurses (RNs),
clinical nurse specialists, nurse practitioners, and PAs (1).
Soon after, the Nursing Education Work Group was
established, and the ACC was awarded a Certiﬁcate of
Accreditation as a provider of continuing nursing educa-
tion from the American Nurses Credentialing Center. In
2007, cardiac care associate membership was extended to
clinical cardiovascular PharmDs. In 2009, the ACC Board
of Trustees approved the designation of Associate of the
American College of Cardiology for APPs with board cer-
tiﬁcation in their respective disciplines and at least
2 years of ACC membership, upon review of formal letters
of recommendation. The ACC Board also approved the
awarding of the title of Fellow of the American College of
Cardiology to APPs with exceptional academic achieve-
ment. In 2010, an APP was added to the Board of Trustees,
becoming the ﬁrst nonphysician member of the board.
During this time, the College increased its focus on car-
diovascular team-based care and APPs though the devel-
opment of several committees, sections, task forces, and
councils. Currently, the College has over 4,600 cardiac
care associate members, reﬂecting the deep and enduring
commitment of the College to its newest group of mem-
bers and to the concept of cardiovascular team-based
care.
In the fall of 2014, the ACC leadership, at the direction
of the Board of Trustees, appointed a multidisciplinary
writing committee to articulate the ACC’s ofﬁcial policy
regarding cardiovascular team-based care as it relates
to the contributions of APPs. The ACC also convened
a daylong “think tank” meeting at Heart House on
November 7, 2014, to examine regulatory, ﬁnancial, and
organizational barriers to achieving optimal cardiovas-
cular team-based care. To facilitate a wide-ranging dis-
cussion, the ACC invited representatives from the
professional societies for nursing, advanced practice RNs,
PAs, and PharmDs; representatives from state licensing
boards and other regulatory agencies; experts in payment
models; representatives from other physician groups; and
chairs of relevant ACC committees. This policy statement
reﬂects the collective contributions of the writing com-
mittee, the think tank meeting, and numerous related
College activities.
The College’s early emphasis on cardiovascular team-
based care was propitious because of anticipated phy-
sician workforce shortages (2) and multiple other
challenges to cardiovascular healthcare delivery. Ourpatients are older, are sicker, and present with more
complicated conditions than ever before, and the ﬁeld of
cardiovascular medicine has become strikingly more
complex. Physicians are accountable for an increasing
number of quality and performance measures and must
fulﬁll public reporting as well as new maintenance of
certiﬁcation requirements, and new, intricate payment
models. Healthcare systems are rapidly consolidating,
and cardiologists are increasingly seeking the security of
integration with hospitals and large healthcare systems
(3,4). Finally, the Affordable Care Act has already added
millions of newly insured patients to the healthcare
market, which, along with the aging population and the
epidemics of obesity and diabetes mellitus, could mark-
edly increase the demand for cardiovascular services (2).
These rapidly changing environmental factors are placing
stress on the practice of cardiovascular medicine in new
and unpredictable ways. Cardiovascular team-based care
models can provide efﬁciencies and other enhancements
that will help physicians and other providers cope with
the demands of today’s practice environment and posi-
tively impact patients and their care.
Many cardiology practices have avidly embraced the
concept of team-based care. Its implementation may vary
depending on the size and setting of a practice, state
regulations, and workforce availability. Other practices
have not adopted team-based care, possibly owing to a
lack of awareness of the capabilities of APPs and the
advantages of multidisciplinary approaches to care de-
livery. Additionally, regulatory or ﬁnancial factors may
also constitute barriers that have inhibited practices from
embracing cardiovascular team-based care.
This position paper focuses on APPs because these
members of the cardiovascular team have the requisite
education, training, and experience to allow them greater
autonomy, thus extending a team’s capabilities. In addi-
tion, other longstanding members of the cardiovascular
team should be recognized for their continued contribu-
tions to effective cardiovascular team-based care. These
team members include registered nurses, licensed prac-
tical nurses, medical assistants, nurse aides, technolo-
gists, nutritionists, genetic counselors, social workers,
and chaplains. These other team members can take on
added responsibilities requiring a high level of skill over
time, but their formal training and licensing requirements
have remained relatively constant, and they are not the
focus of this report. It should be emphasized, however,
that these other team members are highly valued.
This health policy statement will inform ACC members
and the public about the capabilities of APPs, discuss
existing barriers to cardiovascular team-based care, offer
successful examples, and provide recommendations for
improving the provision of cardiovascular team-based
care. Finally, this paper will illustrate ways that
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care that is of higher quality and results in greater patient
and provider satisfaction than any single team member
can provide independently.
2. TRAINING AND QUALIFICATIONS OF
TEAM MEMBERS
Members of the cardiovascular care team come from a
variety of professional disciplines with distinct education
and training pathways, resulting in a rich diversity of
talent and capabilities. The general curriculum for APPs
includes physiology, pathophysiology, pharmacology,
psychology, and varying amounts of clinical experience,
depending on the type of degree. Degree-granting in-
stitutions are accredited according to national standards.
Each APP takes a qualifying examination in his or her
state and is board-certiﬁed by the appropriate national
organization upon successful completion of all necessary
steps. These requirements are listed in Table 1.
Residency and fellowship training programs are well
established for cardiologists, and a variety of opportu-
nities exists for post-graduate training for PharmDs and
PAs. The Accreditation Review Commission on Education
for the Physician Assistant, Inc. is currently revising its
accreditation process for PA post-graduate programs;
however, APRNs (which include both nurse practitioners
and clinical nurse specialists) have few formal opportu-
nities for postgraduate training in cardiovascular care.
The Institute of Medicine Committee on the Future of
Nursing has recommended developing residency training
programs and other additional educational opportunities
for APRNs (5). For both APRNs and PAs, the stated intent
of the established degree program is to provide a general
education in the given ﬁeld. At present, most APPs
working as members of cardiovascular teams receive
their cardiovascular specialty training through informal
apprenticeship training programs developed by individ-
ual practices and hospitals. These advanced and/or spe-
cialty training programs vary in length, are usually
funded by the practices and hospitals in which the APP
is employed, and may last for 3 to 6 months.
As noted, fellowship training and certiﬁcation re-
quirements for cardiologists are well established. Since
1995, the details for training cardiovascular fellows have
been speciﬁed in a series of documents produced by the
ACC called, collectively, the Core Cardiovascular Training
Statement (COCATS) (6). The COCATS documents provide
curricular content for training programs that goes beyond
the broad ACGME minimum requirements for residency
and fellowship. The documents deﬁne progressive levels
of skills and competency in designated areas and provide
a level of speciﬁcity that has informed ABIM requirements
for certiﬁcation. Over the years, these documents havebecome more focused on competency-based training,
curricular milestones, and learner outcomes than on
duration of time or the speciﬁc number of procedures
performed (e.g., coronary angiograms). They help deﬁne
the entrustable professional activities of the cardiology
profession. Interestingly, 1 entrustable professional ac-
tivity in COCATS 4 is the ability to provide cardiovascular
team-based care (team-based care is also listed as a core
competency for residency and fellowship training by
the ACGME). Currently, there are no corresponding doc-
uments that delineate the core competencies of cardio-
vascular APPs.
3. ROLES OF TEAM MEMBERS
The post-graduate training experience of APPs largely
determines their role on a cardiovascular team. All car-
diovascular APPs are taught problem-solving algorithms,
treatment protocols, procedures, and standards for gen-
eral cardiovascular care. Many APPs are taught to practice
in a focused area of cardiovascular care, such as heart
failure.
The diversity of backgrounds for APPs should be
viewed as an asset for the team. For example, nurse
practitioners may be particularly focused on chronic dis-
ease management, patient education, and transitions of
care, whereas clinical nurse specialists may be focused
on developing and improving speciﬁc cardiovascular
programs. The tasks of physician assistants tend to
be modeled on the technical and clinical tasks of the
physicians, thus expanding the overall capabilities of
physician-led teams. PharmDs may be focused on tasks
such as medication reconciliation during care transitions,
improving medication adherence, providing prevention
care, and managing complex drug therapy.
A discussion paper written in 2012 by an Institute of
Medicine roundtable on team-based care deﬁned 5 per-
sonal values or attributes that are frequently seen among
members of well-functioning teams: honesty, discipline,
creativity, humility, and curiosity (7,8). These values are
particularly relevant for cardiovascular care, which can
sometimes be perplexing, stressful, and exhausting.
Teams should be honest and transparent about uncer-
tainty and mistakes. Team members should be disci-
plined regarding their roles and responsibilities and
about when to call for help from a more knowledgeable
or experienced team member. Clinical cardiology calls
for creativity to tackle the unique problems of individual
patients in a patient-centered fashion. The complexity
of cardiovascular medicine demands a degree of humil-
ity and honest recognition of the degree of ambiguity
in clinical practice. Finally, curiosity can engender an
attitude of continuous quality improvement and con-
stant learning. To allow members to grow and develop
TABLE 1 Education, Licensing, Credentialing, Advanced Training, and Certiﬁcation Requirements of Cardiovascular TeamMembers
Requirement Cardiologist APRN PA PharmD RN
Education 4 years for an MD or DO degree
(after obtaining undergraduate
degree) in a school accredited
by the LCME of the AAMC and
AMA or the AOA
2 years for a MSN (after
obtaining an RN/BS or
BSN degree) and 2–3
additional years for
those who choose to
obtain a DNP or 2–4
additional years for
a PhD (completed
within 7 years) in a
school accredited
by the AACN
2–3 years for a PA master’s
degree in a school
accredited by the
ARC-PA (after obtaining
undergraduate degree),
and 1–3 additional years
for those who choose
to obtain a DHSc or
DScPA degree
4 years for a PharmD
(after 2–4 years of
undergraduate
study)
in a school
accredited
by the ACPE
Up to 4 years for a
diploma in nursing,
associate’s degree, or
baccalaureate degree
in nursing in a school
accredited by the
CCNE or ACEN
Testing for
licensure
USMLE examination for
physicians with an MD
degree, or the
COMLEX-USA examination
for physicians with a
DO degree, parts 1–3
Examination administered
by the ANCC, AANP,
and AACN
PANCE administered
by the NCCPA
NAPLEX and state-
speciﬁc
examinations
NCLEX
Licensure State board of medicine State board of nursing
(in some states,
both the board of
nursing and board
of medicine)
State board of medicine
(a few states have a
separate physician
assistant board)
State board of
pharmacy
State board of nursing
Added
certiﬁcations
Not applicable to physicians,
who have ofﬁcial board
certiﬁcations*
E.g., heart failure, lipid
management,
anticoagulation
(ANCC, AACN, or
other certifying
organizations)
E.g., cardiovascular and
thoracic surgery,
emergency medicine,
hospital medicine
(NCCPA), lipid
management
E.g., lipid management,
anticoagulation,
BCPS AQ-
Cardiology
E.g., heart failure, lipid
management,
anticoagulation
(ANCC)
Residency 3 years in a program accredited
by the ACGME or AOA;
certiﬁed by ABIM, AOBIM,
or ABP
Not available Limited availability 1–2 years optional
(ASHP, ACCP)
Not available
Fellowship 3 years in a program accredited
by the ACGME or AOA, with
the 3 years then certiﬁed by
ABIM, AOBIM, or ABP
Very limited availability Limited availability 1–2 years optional
(ASHP, ACCP)
Not available
Advanced
fellowship
1–2 years in a program accredited
by the ACGME or AOA, with
the 1–2 years certiﬁed by the
ABIM or AOBIM
Not available Not available Not available Not available
Maintenance of
licensure
Every 2 years Every 2 years Every 1–2 years Every 1–2 years Every 2 years
Maintenance of
certiﬁcation
(MOC)*
ABIM secure examination every
10 years with record of MOC
activity every 2 years and
demonstration of 100 points
of MOC activity every 5 years,
or OCC for DO physicians
Every 5 years; requires
documentation of
practice hours, of CE
(100 hours), and of
scholarly activities;
retesting if
certiﬁcation has
lapsed
PANRE examination
every 10 years and
documentation of at
least 100 hours of
CME every 2 years
(administered by the
NCCPA)
BCPS (AQ Cardiology)
portfolio review
every 7 years
Every 5 years
*ABIM is currently making revisions to MOC requirements.
AACN ¼ American Association of Colleges of Nursing; AAMC ¼ Association of American Medical Colleges; AANP ¼ American Academy of Nurse Practitioners; ABIM ¼ American Board
of Internal Medicine; ABP ¼ American Board of Pediatrics; ACCP ¼ American College of Clinical Pharmacy; ACEN ¼ Accreditation Commission for Education in Nursing; ACGME ¼
Accreditation Council for Graduate Medical Education; ACPE ¼ Accreditation Council for Pharmacy Education; AMA ¼ American Medical Association; ANCC ¼ American Nurses Cre-
dentialing Center; AOA ¼ American Osteopathic Association; AOBIM ¼ American Osteopathic Board of Internal Medicine; APRN ¼ advanced practice registered nurse; AQ ¼ Added
Qualiﬁcations; ARC-PA ¼ Accreditation Review Commission on Education for the Physician Assistant, Inc.; ASHP ¼ American Society of Health-System Pharmacists; BCPS ¼ Board-
Certiﬁed Pharmacotherapy Specialist; BS ¼ Bachelor of Science; BSN ¼ Bachelor of Science in Nursing; CCNE ¼ Commission on Collegiate Nursing Education; CE ¼ continuing ed-
ucation; CME ¼ continuing medical education; COMLEX-USA ¼ Comprehensive Osteopathic Medical Licensing Examination of the United States; DHSc ¼ Doctor of Health Science;
DNP ¼ Doctorate of Nursing Practice; DO ¼ Doctor of Osteopathic Medicine; DScPA ¼ Doctor of Science Physician Assistant; LCME ¼ Liaison Committee on Medical Education; MOC ¼
maintenance of certiﬁcation; MSN ¼ Masters of Science in Nursing; NAPLEX ¼ North American Pharmacist Licensure Examination; NCCPA ¼ National Commission on Certiﬁcation of
Physician Assistants; NCLEX ¼ National Council Licensure Examination; OCC ¼ Osteopathic Continuing Certiﬁcation; PA ¼ physician assistant; PANCE ¼ Physician Assistant National
Certifying Exam; PANRE ¼ Physician Assistant National Recertifying Exam; PharmD ¼ Doctor of Pharmacy; PhD ¼ Doctor of Philosophy; RN ¼ registered nurse; USMLE ¼ United States
Medical Licensing Examination.
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ual aspirations of each team member. Teams that
espouse these values will deliver more cooperative
and effective cardiovascular team-based care, and willdemonstrate these core team values to the patient and
his or her family.
The most important member of any cardiovascular care
team is the patient (9,10). The patient and the patient’s
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and have the ﬁnal say on the overarching goals of care.
These goals should be clearly articulated and understood
by all members of the care team.
A useful motto for cardiovascular team-based care is
“shared goals and clear roles.” Each team member should
have a clear understanding of his or her functions, re-
sponsibilities, and what is expected of him or her. Team
members’ roles are developed through explicit prepara-
tion and systematic development of speciﬁc knowledge,
skills, interests, and resources. Each member should be
supported by a feeling of mutual trust and guided by
effective communication among team members. Finally,
shared goals should be monitored by measurement and
feedback of the team’s processes and outcomes, with a
clear mechanism for correcting any deﬁciencies (7).
Implementing the motto of “shared goals and clear
roles” will create greater stability in team composition
over time, increasing the reliability and effectiveness of
the team as a whole. The range of activities for each team
member may expand, reﬂecting the accumulating expe-
rience of a team member, and may vary, reﬂecting revised
team goals and tasks. For efﬁciency, members should
have sufﬁcient autonomy to reduce overlap in functions.
Every team should strive to make the highest and best use
of the education, training, experience, and talents of each
team member.
3.1. Leadership
Questions arise regarding who leads cardiovascular
teams. We should re-emphasize that the ultimate leader
for patient care is, of course, the patient. It is the
informed patient, in consultation with family, who should
ultimately determine the goals of cardiovascular team-
based care. The objective of healthcare teams should be
to engage the patient in a constructive collaboration of
care, to seamlessly merge the patient’s desires and aspi-
rations with the science and art of medicine.
As noted by the Institute of Medicine roundtable
on team-based care, issues of leadership are sometimes
entangled with disputes over scope of practice and
whether all teams should be physician-led (7). The Insti-
tute of Medicine roundtable notes that these issues seem
to be less problematic in the ﬁeld than they are in the
political arena, and that observation seems true for car-
diovascular teams as well. Front-line practitioners usually
have no trouble ﬁguring out who is the logical leader of
the team. Leadership of healthcare teams can be situa-
tional, clinical, or managerial, depending on the charge
and the task that the team is undertaking.
Historically, the leader of a cardiovascular team has
been a cardiologist. It is our position that leadership
should be ﬂexible, reﬂecting the speciﬁc needs of the
patient at a particular time and setting. For example, achaplain or a social worker may lead a team meeting to
discuss transition to palliative care; a nurse or a phar-
macist may lead a team that organizes a chronic anti-
coagulation clinic; and an APRN or PA may lead a team
that coordinates transitions of care. The leader should be
the team member with the greatest knowledge and
experience and the best qualiﬁcations for the leadership
task at hand. Organizations should clearly deﬁne dele-
gated leadership roles to provide support for the assigned
leaders and ensure the team’s successful completion of
the task.
For clinical leadership, the most important factor for
determining the leader is the amount of knowledge,
training, and experience a person brings to the task. For
most clinical matters of cardiovascular team-based care,
the overall leader will be a cardiologist. In general, car-
diologists have substantially more training and have the
certiﬁable competencies that patients and the public
expect for leadership and oversight of a clinical cardio-
vascular care team. Well-functioning teams should
readily respect the clinical qualiﬁcations of the clinical
leader, and the clinical leader should match that respect
with a level of humility that will engender candid dia-
logue and feedback among team members.
Managerial leadership is affected by a number of
organizational factors. In academic practice, managerial
leadership is determined by hierarchal academic struc-
tures. In private practice, managerial leadership is usually
determined by ownership and the bylaws of the ﬁrm. In
nonacademic integrated practice, the managerial leader-
ship is determined by comanagement agreements and
legal contracts. For clinical program development, the
cardiologist will be the logical leader for clinical matters,
collaborating with other clinical team members and
administrative partners for overall program development
and supervision.
It should be abundantly clear to all team members and
to patients and families who the leader is for each
particular task. Patients often ask, “Who is in charge?”
They should, therefore, be clearly informed about the
identity of the leader and how other team members will
interact with the leader to accomplish the team’s—and the
patient’s—goals. Some well-functioning teams provide
patients with brochures or web-based guides with pic-
tures of team members and descriptions of their roles,
expectations, and relationships with others on the car-
diovascular team. Patients often identify an APP as their
day-to-day “go-to” person who is most consistently
available to guide them through the confusion of a hos-
pitalization and the transition to the home.
Rather than promoting ﬁxed and inﬂexible rules
regarding team leadership, we should recognize that
the members of the cardiovascular team are professionals,
and as such, are self-regulated. This sense of self-
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ership role goes to the team member who is most qualiﬁed
to lead the team to perform the task at hand in a patient-
centered and responsible fashion.
3.2. Accountability
A well-functioning team should clearly state what is ex-
pected of each team member and the ways in which each
member is accountable for accomplishing speciﬁcally
designated tasks and goals. The team should also be clear
about who has ultimate accountability for the overall
mission of the team, as ambiguity and diffusion of
accountability are detrimental to the quality of patient
care. For both clinical and legal reasons, ultimate
accountability for the clinical care of cardiovascular
patients will continue to rest with the cardiologist.
As a result of the increasing use of public reporting and
pay-for-performance programs, teams are more account-
able for their performance than in the past. Generally,
the performance measures used in these programs are
hospital- or practice-level measures of processes and
outcomes. Policy makers and payers choose performance
measures with measurement feasibility, clinical validity,
and statistical credibility. In addition, there are opportu-
nities for teams to measure performance for internal use
with measures that may not be as statistically robust as
externally reportable measures; these internal measures
can sometimes provide an early signal for continuous
quality improvement.
4. BARRIERS TO BROAD DISSEMINATION OF
CARDIOVASCULAR TEAM-BASED CARE
4.1. Regulatory Barriers
Licensure of practitioners is regulated by states. Each
state and territory in the United States generally has a
Medical Practice Act and a Nurse Practice Act thatTABLE 2 Licensing Requirements of Cardiologists, Advanced Pr
Practitioner
Cardiologist (MD, DO) Graduation from medical school or school of osteo
and successful completion of the USMLE exam
Advanced practice registered
nurse (APRN)
Varies by state, but generally graduation from APR
certiﬁcation examination in appropriate role an
Some states do not license their APRNs.
Physician assistant (PA) Graduation from an accredited physician assistant p
renewal every 2 years.
Pharmacist (PharmD) Graduation from an accredited college or school o
jurisprudence examination; renewal every 1–2 y
Registered nurse (RN) Diploma in nursing, associate or baccalaureate deg
every 2 years.
AACN ¼ American Association of Critical-Care Nurses; AANP ¼ American Academy of Nurse P
registered nurse; NAPLEX ¼ North American Pharmacist Licensure Examination; NCCPA ¼ N
Licensure Examination; USMLE ¼ United States Medical Licensing Examination.establish a board of medicine, a board of nursing, and a
board of pharmacy to regulate the activities of healthcare
practitioners. The laws regarding scopes of practice are
established by statute. State boards can write rules,
enforce laws, and sanction practitioners, but the law-
makers of each state are responsible for writing the
laws that determine licensing requirements and scope-
of-practice regulations.
Licensing requirements for practitioners are listed in
Table 2. In all states, physicians are granted an unre-
stricted license to practice medicine after completing
medical school or a school of osteopathy and 1 year of
internship, and after passing their board examinations.
For physicians, there are no statutory licensing re-
strictions on scope of practice. Instead, any such re-
strictions are largely regulated by hospital credentialing
rules and community standards of care. Physicians (as
well as other practitioners) who practice outside what is
generally accepted as the standard of care for their scope
of practice can be reported to state medical boards and
subjected to hospital disciplinary actions, malpractice
lawsuits, and other legal proceedings with potentially
serious consequences.
PAs are licensed by state boards of medicine in most
states and by physician assistant boards in a few. In all
U.S. states and territories, PAs are licensed to practice
medicine under the supervision of a physician, who has
broad discretion over what clinical activities can be
delegated to a PA. Many states require a formal collabo-
rative practice agreement (CPA) between the PA and a
physician. PAs are granted prescriptive authority in all
50 states.
Pharmacists are licensed by state boards of pharmacy
and may perform certain patient care services within their
scope of practice (e.g., medication reviews, patient edu-
cation and counseling, disease screening, and referral) in
all 50 states. CPAs can expand the services thatactice Providers, and Registered Nurses
Requirement
pathy; 1 year of internship (during which time an interim license is granted);
ination part 3; renewal every 2 years.
N graduate-level program and successful completion of ANCC, AANP, or AACN
d population specialty area; renewal every 2 years.
rogram and successful completion of the NCCPA board certiﬁcation examination;
f pharmacy; successful completion of the NAPLEX examination and state
ears.
ree in nursing, and successful completion of the NCLEX examination; renewal
ractitioners; ANCC ¼ American Nurses Credentialing Center; APRN ¼ advanced practice
ational Commission on Certiﬁcation of Physician Assistants; NCLEX ¼ National Council
J A C C V O L . 6 5 , N O . 1 9 , 2 0 1 5 Brush, Jr. et al.
M A Y 1 9 , 2 0 1 5 : 2 1 1 8 – 3 6 2015 Team-Based Care Health Policy Statement
2125pharmacists provide to patients. A CPA deﬁnes patient
care functions that a pharmacist can provide autono-
mously within the context of a deﬁned protocol (e.g.,
providing patient assessments, counseling, and referrals;
ordering laboratory tests; administering drugs; and
selecting, initiating, monitoring, continuing, and adjust-
ing drug regimens). Currently, 48 states and the District of
Columbia allow CPAs to be created. CPA provisions vary
greatly by state in terms of the extent of the pharmacists’
authorized services, limitations on practice sites and
health conditions, authority to order laboratory tests, and
requirements for pharmacist participation.
APRNs, which include certiﬁed nurse practitioners,
certiﬁed nurse midwives, certiﬁed registered nurse an-
esthetists, and clinical nurse specialists, are licensed by
state boards of nursing. In some states, APRNs are
licensed by both the board of nursing and the board
of medicine. State licensing requirements, regulations
regarding scope of practice, and the limits within which
APRNs can practice vary considerably between states.
Currently, 19 states give APRNs statutory authority to
practice without a written CPA with a supervising physi-
cian. Additionally, 19 states have various requirements
regarding physician involvement for the APRN to pre-
scribe but not to diagnose and treat. Twelve states require
physician involvement to diagnose, treat, and prescribe
(11,12).
In 2010, the Institute of Medicine, in collaboration with
the Robert Wood Johnson Foundation, published a report
entitled The Future of Nursing: Leading Change, Advancing
Health (5). This report called for regulators to allow nurses
to practice “to the full extent of their education and
training” through the elimination of regulatory barriers.
The report also recommended improvements in nursing
education and training, a full-partnership role for nurses
in redesigning the healthcare system, and better work-
force planning and policymaking through better data
and information gathering. It additionally suggested that
changing state regulations to extend the role of nurses
would help alleviate present and future shortages in pri-
mary care. This report has generated considerable con-
troversy between nursing organizations and physician
organizations, particularly those that represent primary
care physicians.
In 2011, the U.S. Surgeon General’s ofﬁce released a
report entitled Improving Patient and Health System
Outcomes through Advanced Pharmacy Practice (13).
This report documents the beneﬁts of pharmacist-
delivered care in many healthcare settings and recom-
mends that healthcare leadership and policy makers
optimize the pharmacist’s role in delivering patient-
centered care and disease prevention services in collab-
oration with physicians or as part of a healthcare team.
The report recognizes that policy, legislation, andcompensation barriers often hinder the expansion of
pharmacist services.
The Future of Nursing, in particular, has created
considerable controversy regarding whether APRNs
should be licensed to practice independently in primary
care settings. The hot-button issues that are part of that
controversy, such as practice independence, competition,
and restraint of trade, are not germane to the present
discussion on cardiovascular team-based care. Issues that
are germane to cardiovascular team-based care, such as
interdependency, cooperation, autonomy, efﬁciency, and
effectiveness, however, are not controversial. By “au-
tonomy,” we mean self-reliant team members who
do not require direct supervision, thereby avoiding
duplication of effort. We distinguish “autonomy” from
“independence,” the latter referring to practitioners
acting alone and not in a team-based model. The heated
controversy about independent practice should not
become a distraction as we work to improve the quality of
cardiovascular team-based care and thereby improve pa-
tient outcomes.
An issue raised in The Future of Nursing that is germane
to cardiovascular team-based care is the wide variability
in prescriptive authority among providers and across
states. Inconsistency between states in terms of what PAs,
APRNs, and PharmDs are licensed to prescribe can
become a barrier to broad-based implementation of car-
diovascular team-based care (5,11). Furthermore, this
state-by-state variability can create impediments to the
development of national consensus documents and na-
tional standards regarding cardiovascular team-based
care. PAs have fairly uniform regulations across states
regarding prescriptive authority. Greater state-by-state
uniformity in the prescriptive authority of APRNs and
PharmDs would be a step forward for improving cardio-
vascular team-based care.
4.2. Payment Barriers
A second barrier for cardiovascular team-based care re-
lates to payment by Medicare and commercial payers. In
general, Medicare payment rules are confusing, complex,
and open to interpretation by ﬁscal intermediaries. Prac-
titioners may be reluctant to embrace cardiovascular
team-based care because of a poor understanding of the
rules and fear of an allegation of payment fraud.
Medicare pays for some services performed by a PA or
nurse practitioner (but not a PharmD) under a physician’s
supervision. Physician supervision is deﬁned as general
(where the physician’s direct presence is not required),
direct (in the ofﬁce setting with the physician in the ofﬁce
suite and immediately available), or personal (with the
physician in the room during the performance of the
procedure). For evaluation and management coding, the
level of physician supervision is 1 factor that determines
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to Medicare rules, physician supervision cannot be dele-
gated to an APP. For example, an APP can perform but not
supervise an exercise stress test.
In the outpatient setting, some APP services can be
covered under the “incident to” designation, which
means that the service is furnished under the direct su-
pervision of a physician by that physician’s employee for
a service that is integral, although incidental, to the
physician’s professional service. This usually pertains to a
follow-up ofﬁce visit provided by an APP, following the
physician’s documented plan of care. When billing “inci-
dent to,” the provider is reimbursed at 100% of the
Medicare reimbursement rate, whereas if service is not
“incident to” and the bill is submitted under the APP, it
would be reimbursed at 85% of the physician rate. For
patients seen by APPs billing “incident to,” the physician
is expected to stay actively involved in the care, with a
direct visit every 6 to 12 months, or more frequently if
necessary.
“Incident to” billing does not apply to care delivered
outside of the ofﬁce setting. In the hospital, the APP role
in cardiovascular team-based care may be “pre-rounding”
on patients who are also seen by the physician and billed
under the physician’s provider number. This is referred to
as a “shared-service” visit, and the documentation must
represent the work of the team. Speciﬁcally, if the visit is
billed this way, the physician must document his or her
direct encounter with the patient and the elements of the
examination, visit, and medical decision-making that he
or she personally provided. The combined documentation
(either a shared note or 2 linked notes) of both the
physician and the APP provides the basis for the billed
code. If an APP sees a patient independently in the hos-
pital, the bill is submitted under the APP and reimbursed
at 85% of the physician rate.
Because pharmacists are not recognized as providers
for Medicare Part B services, they may only bill using the
lowest level reimbursement code (i.e., level 1 or 99211) in
most outpatient clinic settings. The amount of time
needed for an ofﬁce visit for even a moderately complex
patient makes it virtually impossible for a PharmD to
generate enough revenue to offset the cost of seeing
patients in this manner.
New payment codes now allow an APP to bill for tran-
sitional care as well as new chronic care management
services that may not require face-to-face services. Final
rules regarding the ﬂexibility and supervision of chronic
care management are pending. These services will help
improve communication and coordination of cardiovas-
cular team-based care.
Many practices employ APPs in both the ofﬁce and
hospital setting. In the ofﬁce, the APP can provide billable
services that provide both practice income and betteraccess for patients. In the hospital, the APP does not
submit a bill for a shared visit, but the cost of the APP’s
unreimbursed activity can be justiﬁed by the gain in
physician efﬁciency.
Commercial payers have varying policies regarding
APPs. Whereas many have payment policies that are
similar to Medicare, some do not even credential APPs.
The ACC’s payer advocacy members and staff will
continue to advocate for fair APP billing policies.
4.3. Future Payment Models
The future of the fee-for-service payment model is un-
certain. There is much talk about moving from this pay-
ment model that rewards volume to one that rewards
value. In the new models, providers will be paid in-
centives to reach targets for quality, efﬁciency, and pa-
tient satisfaction. Medicare and commercial payers are
actively pursuing several alternative payment models
and the 2 most prominent examples are payment models
associated with accountable care organizations, and
bundled payment models. These new models represent
both an opportunity and a challenge for cardiovascular
team-based care. The key to success will be to assign the
right clinician to the right clinical task and patient at the
right time to enhance efﬁciency and avoid indiscrimin-
ately replacing more-skilled providers with less-skilled
providers (5).
The Secretary of the Department of Health and Human
Services has stated that the Department’s goal is to have
30% of Medicare payments tied to quality and value
through alternative payment models by the end of 2016
and 50% of payments by the end of 2018 (14). Medicare is
currently implementing these new payment models
through programs such as the Pioneer Accountable Care
Organization model and the Medicare Shared Savings
Program. In these models, practitioners share a varying
degree of ﬁnancial risk and are rewarded for improved
efﬁciency while meeting speciﬁed quality performance
targets. Medicare is also implementing bundled payment
programs for acute care (delivered at the time of an index
hospital admission), for acute and postacute care (which
includes care given for 30 days after an index admission),
and for postacute care alone. In addition, Medicare is now
applying ﬁnancial penalties and bonuses to hospitals
through its value-based payment program on the basis of
30-day mortality rates and 30-day readmission rates for
particular conditions, including acute myocardial infarc-
tion and congestive heart failure. These global and
bundled payment models will reframe the value agenda
to include measures of patient satisfaction and efﬁciency
and will create ﬁnancial incentives for greater coordina-
tion and consolidation of care. It remains to be seen
whether the payments will be sufﬁcient to adequately
support the provision of cardiovascular team-based care.
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uted internally will be an administrative challenge for
cardiovascular teams.
Commercial health plans are also implementing new
payment models through the patient-centered medical
home model, including additional per-member, per-
month payments for coordinating care and achieving
certain quality targets. In addition, health plans are
implementing accountable care organization models for
the commercial population.
Going forward, the challenge for cardiovascular team-
based care will be to successfully navigate the transition
to new payment models. It will be extraordinarily difﬁcult
to provide high-quality care in a “mixed” transition
environment. This looming challenge is 1 reason why so
many cardiology practices have integrated into large
health systems. Integration and cardiovascular team-
based care may help mitigate the difﬁculty that pro-
viders will encounter as they transition to these new
payment models.
5. EXAMPLES OF EFFECTIVE
CARDIOVASCULAR TEAM-BASED CARE
The cardiovascular ﬁeld has pioneered many models of
cardiovascular team-based care. Examples of cardiovas-
cular team-based care are listed in Table 3.
Clinics for patients with chronic and advanced heart
failure have a long history and extensive experience in
cardiovascular team-based care (15). A 2011 national sur-
vey of programs that followed patients with chronic heart
failure, cardiac transplants, and mechanical circulatory
support devices included 257 unique practices in the
United States (16). Average stafﬁng utilization constitutedTABLE 3 Examples of Cardiovascular Team-Based Care
Setting APP or RN
Hospital transitions of care Transitional care model (17,24,25)
Chronic heart failure management Disease-state management (15,16)
Lipid clinics Disease-state management
Hypertension clinics Disease-state management
Anticoagulation clinics Disease-state management
Exercise stress laboratories Care supervision (22)
Structural heart programs Care coordination (23)
Arrhythmia management for pacemakers and
implantable cardioverter-deﬁbrillators
Disease-state management
Cardiology-speciﬁc medical home Disease-state management
Outreach to rural clinics and remote locations Disease-state management
APP ¼ advanced practice providers; RN ¼ registered nurse.2.65 physician full-time equivalents, 2.21 APP full-time
equivalents, and 2.61 RN coordinator full-time equiva-
lents. The survey noted that as programs grow, physi-
cians, APPs, and RNs are hired in equivalent numbers
to meet the expanding needs of a larger patient popula-
tion. These teams used a variety of methods, including
telephone monitoring, electronic home monitoring, and
web-based assessment to extend the reach of care. This
survey reminds us of the important role provided by RNs,
in addition to physicians and APPs, in cardiovascular
team-based care. By working in teams, heart failure clinic
providers have been able to adjust to both the expanding
numbers of patients and the increasing intensity of care
that patients require.
The ACC’s Hospital-To-Home (H2H) quality improve-
ment initiative is an effort to reduce hospital readmission
rates by improving the transition to the outpatient setting
for patients with congestive heart failure and acute
myocardial infarction (17). The initiative encourages
the use of speciﬁc strategies for smoothing the transition
to outpatient care. A key aspect of the project is to
encourage the use of teams, including PharmDs and
nurses, to ensure optimal discharge medication manage-
ment, and to educate patients to be self-activated
regarding the signs and symptoms of recurring problems.
Another early example of cardiovascular team-based
care is the Cardiac Hospitalization Atherosclerosis Man-
agement Program, established in 1994 at the University of
California at Los Angeles (18). This cardiovascular team-
based care program has shown improvements in the
provision of evidence-based therapies in a chronic care
setting.
Kaiser Permanente of Colorado has developed the
Collaborative Cardiac Care Service. This care model isAdvantage
Reduced readmissions
Reduced hospitalizations, reliable use of evidence-based therapies,
dose titrations, consistent documentation of education
Reliable use of evidence-based therapies, consistent documentation of
lifestyle education
Improved blood pressure control, better use of evidence-based therapies,
reliable documentation of lifestyle education
Improved patient safety through reliable education and assessment,
drug/food interaction monitoring, and improved time in therapeutic range
Efﬁcient use of workforce
Improved access and care coordination
Improved access and care coordination
Improved access and care coordination
Improved access, connected by telemedicine and electronic health records
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in direct patient care roles. The program uses an elec-
tronic medical record, patient-tracking software, and
telephone follow-up to apply reliable, evidence-based
therapies for chronic disease management and risk fac-
tor modiﬁcation and to provide education to patients and
other team members. The model has reported substantial
improvements in patient outcomes (19,20).
The unique Grand-Aides Program employs APPs or RNs
as supervisors and nurse aides or community health
workers as nurse extenders who visit patients in their
homes to educate, monitor, and optimize adherence to
medications and dietary restrictions and to reconcile
medications in the home—all under the direct video su-
pervision of an APP (21). This is a new concept that
promises to improve readmission rates and other out-
comes. The early data show a 58% reduction in heart
failure readmissions (21).
Another example of cardiovascular team-based care is
in the cardiac stress-testing laboratory. A recent scientiﬁc
statement from the American Heart Association articu-
lated a clear set of guidelines for the training and super-
vision of team members that ensures patient safety
and quality in the cardiac stress laboratory (22). Non-
physicians (usually APPs) directly monitor most routine
stress tests under the supervision of a cardiologist, with
clear delineation of roles and responsibilities being para-
mount to ensure patient safety. Current Medicare rules
require direct physician supervision for reimbursement
for cardiac stress testing, but revised payment rules could
enable APPs to perform these tasks with greater
ﬂexibility.
The medical literature is full of examples of team-based
care in integrated healthcare systems. APPs have been an
essential component of multidisciplinary heart teams that
have introduced complex new technologies, such as
transcatheter aortic valve replacement, into cardiovas-
cular practice (23). Cardiac rehabilitation programs and
anticoagulation clinics have relied on team-based care
over the years. There are also many unpublished exam-
ples in communities across the country in which inde-
pendent practices have effectively embraced the concept
of team-based cardiovascular care. Cardiovascular teams
will continue to deﬁne new and creative examples of
team-based care to address future challenges.
6. OPPORTUNITIES TO IMPROVE
CARDIOVASCULAR TEAM-BASED CARE
Broad dissemination of cardiovascular team-based care
paradigms will be realized by further educating the car-
diology community about their components, characteris-
tics, and potential to improve patient outcomes. This
document is meant to fulﬁll this educational opportunityby informing ACC members and others about the value
and potential of APPs in cardiovascular team-based care.
The creation of a COCATS-equivalent Task Force that
speciﬁcally focuses on APRN, PA, and PharmD cardio-
vascular training could provide an opportunity to
improve the training and certiﬁcation of APPs. Most APPs
receive their cardiovascular training in hospitals and
practices across the country, without a set of standard
core competencies or training milestones. A COCATS-
equivalent Task Force on APRN, PA, and PharmD
education could provide national consensus on core
competencies, guidance on how APPs should be trained,
and delineation of their expected contribution to the
cardiovascular team. Currently, nurse practitioners, PAs,
and PharmDs have different educational pathways, and a
COCATS-type document could reduce or eliminate the
problem associated with different training silos while
respecting the uniqueness of the different disciplines. It
would further beneﬁt APPs if the COCATS-type document
deﬁned a certiﬁable level of competency that could be
transported from employer to employer. Thus, a COCATS-
type document for APPs could lead the way to more
consistent training and more reliable attainment of
core competencies, and could spur the development of
specialty certiﬁcations for APPs in cardiology.
There are opportunities to expand interprofessional
education that will enable APPs to attain and maintain the
knowledge and technical skills required for optimal per-
formance in the rapidly changing ﬁeld of cardiovascular
medicine (26,27). Interprofessional education facilitates
greater interaction among providers across different dis-
ciplines. The interaction leads to conversations that can
inspire new thinking and ideas for improving cardiovas-
cular team-based care and can help dispel lingering,
misguided professional stereotypes (28). The ACC should
develop combined programs and purposeful educational
opportunities that meet the learning needs of APPs and
should work with nursing, physician assistant, and phar-
macy organizations to ensure that these educational ef-
forts are aligned with the educational strategies of the
respective professional organizations.
The ACC will continue its advocacy efforts for sensible
payment reforms and should continue to work on the
design of cardiovascular team-based care that meets the
future clinical demands in a way that conforms to
emerging payment models.
Finally, the ACC will continue to explore emerging
technologies that extend the capabilities of cardiovascu-
lar team-based care, including telemedicine and virtual
teams. Having established the value of team-based care,
ACC activities can now work creatively to develop team-
based care models that expand the reach of cardiovas-
cular care and enable geographic extensions of care to
underserved regions.
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21297. SUMMARY
The mission of the American College of Cardiology is “to
transform cardiovascular care and improve heart health.”
Cardiovascular team-based care is a paradigm for practice
that can transform care, improve heart health, and help
meet the demands of the future. One strategic goal of the
College is to help members successfully transition their
clinical practices to the future, with all its complexity,
challenges, and opportunities. The ACC’s strategic plan is
aligned with the triple aim of improved care, improved
population health, and lower costs per capita. The tradi-
tional understanding of quality, access, and cost is that
you cannot improve one component without diminishing
the others. With cardiovascular team-based care, it is
possible to achieve the triple aim of improving quality,
access, and cost simultaneously to also improve cardio-
vascular health. Striving to serve the best interests of
patients is the true north of our guiding principles. Car-
diovascular team-based care is a model that can improve
care coordination and communication and allow each
team member to focus more on the quality of care. In
addition, the cardiovascular team-based care model in-
creases access to cardiovascular care and allows expan-
sion of services to populations and geographic areas that
are currently underserved.
This document will increase awareness of the impor-
tant components of cardiovascular team-based care andcreate an opportunity for more discussion about the most
creative and effective means of implementing it. We hope
that this document will stimulate further discussions and
activities within the ACC and beyond about team-based
care. We have identiﬁed areas that need improvement,
speciﬁcally in APP education and state regulation. The
document encourages the exploration of collaborative
care models that should enable team members to opti-
mize their education, training, experience, and talent.
Improved team leadership, coordination, collaboration,
engagement, and efﬁciency will enable the delivery of
higher-value care to the betterment of our patients and
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